UA74045C2 - Суспензія, що містить фібриноген, тромбін і спирт, спосіб готування такої суспензії, спосіб нанесення на носій покриття із такої суспензії, спосіб сушіння суспензії фібриногену, тромбіну і спирту, нанесеної на поверхню носія, колагенова губка з нанесеним покриттям з фібриногену і тромбіну, застосування колагенової губки з нанесеним покриттям для склеювання і закриття тканин і гемостазу - Google Patents

Суспензія, що містить фібриноген, тромбін і спирт, спосіб готування такої суспензії, спосіб нанесення на носій покриття із такої суспензії, спосіб сушіння суспензії фібриногену, тромбіну і спирту, нанесеної на поверхню носія, колагенова губка з нанесеним покриттям з фібриногену і тромбіну, застосування колагенової губки з нанесеним покриттям для склеювання і закриття тканин і гемостазу Download PDF

Info

Publication number: UA74045C2
Authority: UA; Ukraine
Prior art keywords: suspension; thrombin; fibrinogen; carrier; collagen
Prior art date: 2001-01-25

Application number

UA2003087940A

Other languages

English (en)

Russian (ru)

Ukrainian (uk)

Inventor

Альфред Шауфлер

Original Assignee

Нікомед Фарма Ас

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-25

Filing date

2002-01-25

Publication date

2005-10-17

2002-01-25 Application filed by Нікомед Фарма Ас filed Critical Нікомед Фарма Ас

2002-01-25 Priority claimed from PCT/IB2002/001454 external-priority patent/WO2002058750A2/en

2005-10-17 Publication of UA74045C2 publication Critical patent/UA74045C2/uk

Links

239000000725 suspension Substances 0.000 title claims abstract description 177
239000000515 collagen sponge Substances 0.000 title claims abstract description 137
238000000576 coating method Methods 0.000 title claims abstract description 125
239000011248 coating agent Substances 0.000 title claims abstract description 121
108090000190 Thrombin Proteins 0.000 title claims abstract description 118
238000000034 method Methods 0.000 title claims abstract description 118
229960004072 thrombin Drugs 0.000 title claims abstract description 118
108010049003 Fibrinogen Proteins 0.000 title claims abstract description 117
102000008946 Fibrinogen Human genes 0.000 title claims abstract description 117
229940012952 fibrinogen Drugs 0.000 title claims abstract description 117
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 113
238000001035 drying Methods 0.000 title claims abstract description 40
238000004026 adhesive bonding Methods 0.000 title claims abstract description 7
230000023597 hemostasis Effects 0.000 title claims abstract description 6
238000002360 preparation method Methods 0.000 title claims description 36
238000007789 sealing Methods 0.000 title abstract description 3
239000000203 mixture Substances 0.000 claims abstract description 128
108010035532 Collagen Proteins 0.000 claims abstract description 76
102000008186 Collagen Human genes 0.000 claims abstract description 76
229920001436 collagen Polymers 0.000 claims abstract description 76
239000002245 particle Substances 0.000 claims abstract description 34
238000002156 mixing Methods 0.000 claims abstract description 28
108010039627 Aprotinin Proteins 0.000 claims abstract description 16
229960004405 aprotinin Drugs 0.000 claims abstract description 16
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims abstract description 16
241000283690 Bos taurus Species 0.000 claims abstract description 13
235000019441 ethanol Nutrition 0.000 claims description 72
239000000512 collagen gel Substances 0.000 claims description 33
239000006260 foam Substances 0.000 claims description 32
238000012360 testing method Methods 0.000 claims description 18
239000000463 material Substances 0.000 claims description 14
229960003766 thrombin (human) Drugs 0.000 claims description 13
238000000926 separation method Methods 0.000 claims description 12
238000004519 manufacturing process Methods 0.000 claims description 11
JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 9
238000003756 stirring Methods 0.000 claims description 9
238000005299 abrasion Methods 0.000 claims description 8
238000000265 homogenisation Methods 0.000 claims description 8
239000012298 atmosphere Substances 0.000 claims description 6
235000014655 lactic acid Nutrition 0.000 claims description 6
239000004310 lactic acid Substances 0.000 claims description 6
230000002906 microbiologic effect Effects 0.000 claims description 6
108010088751 Albumins Proteins 0.000 claims description 4
102000009027 Albumins Human genes 0.000 claims description 4
229910001385 heavy metal Inorganic materials 0.000 claims description 3
230000005484 gravity Effects 0.000 claims description 2
150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 2
108010080379 Fibrin Tissue Adhesive Proteins 0.000 abstract description 8
241000282414 Homo sapiens Species 0.000 abstract description 5
239000003570 air Substances 0.000 description 33
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 22
239000000523 sample Substances 0.000 description 21
210000002435 tendon Anatomy 0.000 description 17
230000008021 deposition Effects 0.000 description 16
229940106780 human fibrinogen Drugs 0.000 description 15
206010052428 Wound Diseases 0.000 description 12
208000027418 Wounds and injury Diseases 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 11
229960002477 riboflavin Drugs 0.000 description 11
235000019192 riboflavin Nutrition 0.000 description 11
239000002151 riboflavin Substances 0.000 description 11
239000000243 solution Substances 0.000 description 11
108010073385 Fibrin Proteins 0.000 description 10
102000009123 Fibrin Human genes 0.000 description 10
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 10
229950003499 fibrin Drugs 0.000 description 10
239000003292 glue Substances 0.000 description 9
239000004816 latex Substances 0.000 description 9
229920000126 latex Polymers 0.000 description 9
239000007787 solid Substances 0.000 description 9
230000000740 bleeding effect Effects 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
229910000831 Steel Inorganic materials 0.000 description 7
238000001839 endoscopy Methods 0.000 description 7
238000005194 fractionation Methods 0.000 description 7
239000010959 steel Substances 0.000 description 7
238000001291 vacuum drying Methods 0.000 description 7
239000008215 water for injection Substances 0.000 description 7
238000001816 cooling Methods 0.000 description 6
238000011534 incubation Methods 0.000 description 6
239000007788 liquid Substances 0.000 description 6
230000029058 respiratory gaseous exchange Effects 0.000 description 6
238000001356 surgical procedure Methods 0.000 description 5
206010042674 Swelling Diseases 0.000 description 4
238000002674 endoscopic surgery Methods 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
239000004033 plastic Substances 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
108090000623 proteins and genes Proteins 0.000 description 4
239000000126 substance Substances 0.000 description 4
230000008961 swelling Effects 0.000 description 4
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
230000008901 benefit Effects 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
239000000969 carrier Substances 0.000 description 3
230000015271 coagulation Effects 0.000 description 3
238000005345 coagulation Methods 0.000 description 3
229940079593 drug Drugs 0.000 description 3
239000003814 drug Substances 0.000 description 3
239000011521 glass Substances 0.000 description 3
230000002439 hemostatic effect Effects 0.000 description 3
244000000010 microbial pathogen Species 0.000 description 3
210000001724 microfibril Anatomy 0.000 description 3
230000002572 peristaltic effect Effects 0.000 description 3
238000004321 preservation Methods 0.000 description 3
241000283073 Equus caballus Species 0.000 description 2
108010077465 Tropocollagen Proteins 0.000 description 2
230000009471 action Effects 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
210000000476 body water Anatomy 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000004140 cleaning Methods 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
238000010586 diagram Methods 0.000 description 2
239000012530 fluid Substances 0.000 description 2
230000035876 healing Effects 0.000 description 2
239000006101 laboratory sample Substances 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
238000005259 measurement Methods 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
210000001331 nose Anatomy 0.000 description 2
230000000704 physical effect Effects 0.000 description 2
238000006116 polymerization reaction Methods 0.000 description 2
229920001296 polysiloxane Polymers 0.000 description 2
230000008569 process Effects 0.000 description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
230000009467 reduction Effects 0.000 description 2
239000002893 slag Substances 0.000 description 2
238000009827 uniform distribution Methods 0.000 description 2
SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
108010080865 Factor XII Proteins 0.000 description 1
102000000429 Factor XII Human genes 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229920002201 Oxidized cellulose Polymers 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
208000002847 Surgical Wound Diseases 0.000 description 1
208000018756 Variant Creutzfeldt-Jakob disease Diseases 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
238000013019 agitation Methods 0.000 description 1
239000012080 ambient air Substances 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
229960002684 aminocaproic acid Drugs 0.000 description 1
235000011114 ammonium hydroxide Nutrition 0.000 description 1
239000003708 ampul Substances 0.000 description 1
229940030225 antihemorrhagics Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
238000005452 bending Methods 0.000 description 1
210000003445 biliary tract Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
208000005881 bovine spongiform encephalopathy Diseases 0.000 description 1
244000309466 calf Species 0.000 description 1
238000013130 cardiovascular surgery Methods 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
230000001112 coagulating effect Effects 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
RKTYLMNFRDHKIL-UHFFFAOYSA-N copper;5,10,15,20-tetraphenylporphyrin-22,24-diide Chemical compound [Cu+2].C1=CC(C(=C2C=CC([N-]2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3[N-]2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 RKTYLMNFRDHKIL-UHFFFAOYSA-N 0.000 description 1
210000004087 cornea Anatomy 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
230000003670 easy-to-clean Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000835 fiber Substances 0.000 description 1
230000020764 fibrinolysis Effects 0.000 description 1
102000034240 fibrous proteins Human genes 0.000 description 1
108091005899 fibrous proteins Proteins 0.000 description 1
-1 for example Chemical compound 0.000 description 1
239000012634 fragment Substances 0.000 description 1
238000005469 granulation Methods 0.000 description 1
230000003179 granulation Effects 0.000 description 1
239000002874 hemostatic agent Substances 0.000 description 1
230000003116 impacting effect Effects 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000003993 interaction Effects 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
210000004126 nerve fiber Anatomy 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
229940107304 oxidized cellulose Drugs 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000008188 pellet Substances 0.000 description 1
229940012957 plasmin Drugs 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000002994 raw material Substances 0.000 description 1
238000002271 resection Methods 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
238000003860 storage Methods 0.000 description 1
230000007847 structural defect Effects 0.000 description 1
239000000758 substrate Substances 0.000 description 1
235000012976 tarts Nutrition 0.000 description 1
238000010257 thawing Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
230000029663 wound healing Effects 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

UA2003087940A 2001-01-25 2002-01-25 Суспензія, що містить фібриноген, тромбін і спирт, спосіб готування такої суспензії, спосіб нанесення на носій покриття із такої суспензії, спосіб сушіння суспензії фібриногену, тромбіну і спирту, нанесеної на поверхню носія, колагенова губка з нанесеним покриттям з фібриногену і тромбіну, застосування колагенової губки з нанесеним покриттям для склеювання і закриття тканин і гемостазу UA74045C2 (uk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200100135		2001-01-25
PCT/IB2002/001454 WO2002058750A2 (en)	2001-01-25	2002-01-25	A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same

Publications (1)

Publication Number	Publication Date
UA74045C2 true UA74045C2 (uk)	2005-10-17

Family

ID=34560110

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
UA2003087940A UA74045C2 (uk)	2001-01-25	2002-01-25	Суспензія, що містить фібриноген, тромбін і спирт, спосіб готування такої суспензії, спосіб нанесення на носій покриття із такої суспензії, спосіб сушіння суспензії фібриногену, тромбіну і спирту, нанесеної на поверхню носія, колагенова губка з нанесеним покриттям з фібриногену і тромбіну, застосування колагенової губки з нанесеним покриттям для склеювання і закриття тканин і гемостазу
UA2003087941A UA74046C2 (en)	2001-01-25	2002-01-25	Solid composition containing solid fibrinogen and solid thrombin which is useful for tissue gluing, tissue sealing and bleeding arrest, method for gluing and sealing tissues, method for bleeding arrest

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
UA2003087941A UA74046C2 (en)	2001-01-25	2002-01-25	Solid composition containing solid fibrinogen and solid thrombin which is useful for tissue gluing, tissue sealing and bleeding arrest, method for gluing and sealing tissues, method for bleeding arrest

Country Status (4)

Country	Link
EC (1)	ECSP034747A (es)
UA (2)	UA74045C2 (es)
UY (1)	UY27139A1 (es)
ZA (3)	ZA200305591B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN112891610A (zh) *	2021-01-25	2021-06-04	上海利康瑞生物工程有限公司	猪源纤维蛋白-静电纺丝纳米纤维抗菌止血贴剂及制备方法

2002
- 2002-01-25 UA UA2003087940A patent/UA74045C2/uk unknown
- 2002-01-25 UA UA2003087941A patent/UA74046C2/xx unknown
- 2002-01-25 UY UY27139A patent/UY27139A1/es not_active Application Discontinuation
2003
- 2003-07-18 ZA ZA200305591A patent/ZA200305591B/en unknown
- 2003-07-18 ZA ZA200305588A patent/ZA200305588B/en unknown
- 2003-07-18 ZA ZA200305592A patent/ZA200305592B/en unknown
- 2003-08-25 EC EC2003004747A patent/ECSP034747A/es unknown

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN112891610A (zh) *	2021-01-25	2021-06-04	上海利康瑞生物工程有限公司	猪源纤维蛋白-静电纺丝纳米纤维抗菌止血贴剂及制备方法

Also Published As

Publication number	Publication date
ZA200305588B (en)	2004-10-18
UY27139A1 (es)	2002-08-30
ZA200305592B (en)	2004-10-18
UA74046C2 (en)	2005-10-17
ZA200305591B (en)	2004-10-18
ECSP034747A (es)	2004-01-28

Publication	Publication Date	Title
EA006686B1 (ru)	2006-02-24	Суспензия, содержащая фибриноген, тромбин и спирт, способ её получения, способ нанесения покрытия, способ сушки покрытия и коллагеновая губка с покрытием
US20050214277A1 (en)	2005-09-29	Suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
AU2004206150B2 (en)	2009-10-29	Hemostatic materials
AU2002307809A1 (en)	2003-02-06	A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
US5989215A (en)	1999-11-23	Fibrin delivery device and method for forming fibrin on a surface
US6461325B1 (en)	2002-10-08	Fibrin delivery device and method for forming fibrin on a surface
US9302026B2 (en)	2016-04-05	Method for improved fibrin sealing
UA74045C2 (uk)	2005-10-17	Суспензія, що містить фібриноген, тромбін і спирт, спосіб готування такої суспензії, спосіб нанесення на носій покриття із такої суспензії, спосіб сушіння суспензії фібриногену, тромбіну і спирту, нанесеної на поверхню носія, колагенова губка з нанесеним покриттям з фібриногену і тромбіну, застосування колагенової губки з нанесеним покриттям для склеювання і закриття тканин і гемостазу
RU2063175C1 (ru)	1996-07-10	Способ остановки кровотечения
WO1999010019A2 (en)	1999-03-04	Heterofunctional tissue engineering compositions
CN120981258A (zh)	2025-11-18	用于密封组织中的渗漏的止血密封剂粉末
Jackson	2000	Fibrin sealant as a hemostatic agent in vascular surgery

Info

Links

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=34560110

Family Applications (2)

Family Applications After (1)

Country Status (4)

Cited By (1)

Cited By (1)

Also Published As

Similar Documents